EM1602G "Management of Advanced Hepatocellular Carcinoma" (IM GR020516)

To review the systemic treatment of unresectable Hepatocellular Carcinoma.

Download Protocol

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Understand the challenges and goals of systemic therapy for HCC.
  • Understand the history of clinical trials in advanced HCC.
  • Define the standard of care for advanced, unresectable HCC.
  • Overview of failed therapies tested in Phase 3 trials.
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
Course expires: 

Photo: Hao Zhu, M.D.Hao Zhu, M.D.
Assistant Professor
Children’s Medical Center Research Institute and Pediatrics
Division of Hematology and Oncology

Available Credit

  • 1.00 AMA


Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome